Yttrium radiation liquid for cyst-like brain tumors near the pituitary
Part of Brain & nervous system, Cancer, Genetic & congenital clinical trials.
This Phase 3 trial studies a radioactive liquid called yttrium colloid (90Y) given around the time of surgery for cyst-like tumors near the pituitary gland. The goal is to see if it can improve treatment when you need an operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 17 or older.
- Your tumor is a cyst-like mass near the pituitary area (sellar/suprasellar/parasellar/intrasellar), shown on imaging or tumor cell/tissue tests.
- Your neurosurgeon believes surgery is needed for your tumor and you can safely have an operation.
- Your tumor size/volume can be measured from tests so the study can track it.
- You are treated through the Halifax Neuropituitary Program surgical clinic and can consent to surgery and trial participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new targeted radiation therapy for lymphoma that has spread to the brain or spinal cord and has not responded to other treatments. The treatment uses a radioactive molecule (yttrium-90) attached to a substance that homes in on a specific marker (CXCR4) on the lymphoma cells, aiming to destroy them while limiting damage to healthy tissue.
This study tests a special type of radiation therapy called Y-90 TARE (using radioactive beads delivered directly to liver tumors) to find the safest and most effective dose. It's for people with liver cancer or other liver tumors that cannot be removed by surgery.
This study observes people with colorectal cancer that has spread to the liver and cannot be removed by surgery. It looks at how well a treatment called SIR-Spheres (tiny radioactive beads) works after other treatments have failed.
This trial tests a radiation treatment called Y-90 given before liver surgery for colorectal cancer that has spread to the liver. The goal is to help the liver grow enough for safer, curative surgery, either right away or as part of a two-step operation.
This study tests whether a targeted radiation treatment called Y-90 segmentectomy can shrink liver tumors. It is for people with one to three small liver tumors that cannot be removed by surgery or destroyed by heat or cold (ablation).
This trial tests a treatment that places tiny radioactive seeds directly into some of your tumors, combined with your usual cancer therapy. It is for people who have 6 to 10 tumors that have spread to other parts of the body (not the brain). The goal is to see if adding this implant procedure helps control the tumors better.
Hear when a new Cystic Tumors of the Sellar/Parasellar Region trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.